data_2e36_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e36 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -113.52 139.99 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.428 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 4' ' ' VAL . 29.3 tttm -175.9 82.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 3' ' ' LYS . 1.2 p -38.38 145.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 6' ' ' ALA . 34.9 m -108.44 -32.96 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' ILE . . . -153.3 141.84 20.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -145.15 115.91 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.877 . . . . 0.0 109.149 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.86 114.91 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -114.31 114.53 26.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.497 ' H ' HG21 ' A' ' 55' ' ' VAL . 2.4 tp -157.55 -176.52 6.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.124 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -114.84 120.48 40.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.0 109.476 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.28 151.55 45.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.366 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.89 123.08 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.601 1.534 . . . . 0.0 112.361 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -75.78 129.02 36.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.928 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.604 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 67.45 47.71 61.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -176.85 -21.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.801 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.98 144.22 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.581 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.687 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -131.64 162.75 54.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.44 16.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.543 1.496 . . . . 0.0 113.012 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.03 58.52 15.74 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.427 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.1 Cg_endo -70.39 169.9 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.58 1.52 . . . . 0.0 112.449 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.9 -6.91 5.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.478 1.452 . . . . 0.0 111.673 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.501 ' O ' ' C ' ' A' ' 24' ' ' GLY . 91.4 t -114.87 -54.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.531 -0.731 . . . . 0.0 109.135 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 23' ' ' VAL . . . 36.21 -99.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' VAL . 11.6 Cg_exo -46.62 -43.41 22.93 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.325 1.35 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.68 -5.02 26.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.349 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -97.13 -43.89 7.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.426 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.74 73.45 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.662 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.2 tm0? -123.86 6.55 8.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.332 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.678 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 7.1 p80 -116.16 -47.24 2.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.66 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -152.63 -2.69 0.18 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 79.37 57.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 109.521 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.678 ' OD1' ' CE1' ' A' ' 30' ' ' HIS . 4.3 m120 -133.36 102.46 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG23 HD11 ' A' ' 34' ' ' ILE . 47.0 mm -88.17 -39.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 109.832 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.604 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -61.3 -66.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -0.963 . . . . 0.0 109.486 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.57 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -34.68 -45.83 0.26 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 108.788 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.651 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -58.93 -66.91 0.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.97 -36.62 76.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.213 -0.929 . . . . 0.0 109.909 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 35' ' ' MET . 4.7 tptm -48.97 -61.78 1.88 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.297 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.49 79.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' O ' ' C ' ' A' ' 42' ' ' ASN . 18.3 t80 -47.56 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.1 m-80 -38.52 -43.57 0.87 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.87 -56.78 9.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 108.806 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -63.96 -53.59 47.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.192 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.604 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -65.28 -12.99 57.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.435 -0.791 . . . . 0.0 109.475 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -90.86 -30.62 16.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.097 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -82.69 -33.05 27.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.315 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.709 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -86.49 -77.93 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.709 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 177.69 -160.57 27.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 11.4 t70 -96.06 153.0 18.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 168.72 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.956 . . . . 0.0 109.768 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -124.77 148.81 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.496 ' CG1' ' OG1' ' A' ' 69' ' ' THR . 1.1 t -144.33 120.89 6.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.767 -1.208 . . . . 0.0 110.908 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -68.47 85.84 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.227 1.285 . . . . 0.0 111.551 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG21 ' H ' ' A' ' 10' ' ' LEU . 3.5 m -57.16 149.82 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.03 . . . . 0.0 110.374 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -138.51 53.48 1.79 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mt -57.91 97.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.27 0.557 . . . . 0.0 110.172 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.87 97.49 10.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.718 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' ALA . 91.5 mt -82.06 110.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' O ' ' C ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -88.85 149.75 23.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.518 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -32.83 -55.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.877 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' C ' ' A' ' 63' ' ' ARG . 14.9 m-20 -62.45 43.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.298 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.676 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 36.49 49.7 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.193 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -110.18 117.27 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -101.61 98.82 9.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.109 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -102.02 125.41 48.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.649 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 55.2 p90 -172.0 119.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.94 112.45 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 108.456 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.496 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 8.1 t -155.98 138.01 14.54 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' CG ' ' C ' ' A' ' 69' ' ' THR . 6.2 mttt -151.02 -73.15 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 109.404 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.589 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 0.1 OUTLIER -89.29 164.05 31.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 71' ' ' THR . 25.9 Cg_exo -32.46 162.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.062 1.841 . . . . 0.0 112.842 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' TYR . 37.1 Cg_exo -36.1 -109.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.472 2.115 . . . . 0.0 113.793 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.615 ' C ' ' O ' ' A' ' 73' ' ' PRO . . . -14.35 -48.94 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.657 -0.652 . . . . 0.0 111.469 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.05 -31.72 65.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.702 ' N ' ' O ' ' A' ' 73' ' ' PRO . 9.6 p90 -30.76 -40.36 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.584 -0.698 . . . . 0.0 110.392 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -137.4 -18.06 1.3 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.955 -1.091 . . . . 0.0 108.868 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.629 ' O ' ' N ' ' A' ' 82' ' ' ALA . 32.5 mt -64.38 -31.41 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.531 ' NE ' ' OG1' ' A' ' 71' ' ' THR . 12.0 mtm180 -54.85 -72.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 108.96 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.82 -40.88 61.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 108.796 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.78 72.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.327 -0.858 . . . . 0.0 109.113 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.629 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -81.22 -74.98 0.3 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' GLU . . . 160.87 6.11 0.05 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.71 74.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -1.115 . . . . 0.0 109.32 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLY . 14.1 mt-10 -86.01 -101.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.546 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 87' ' ' GLY . 28.0 mttp -131.25 165.13 24.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.608 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 86' ' ' LYS . . . -42.29 -34.82 1.66 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 65.1 134.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -1.183 . . . . 0.0 109.363 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -34.47 78.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.387 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.7 150.0 37.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 93' ' ' ARG . 2.8 Cg_endo -57.05 135.05 68.45 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.305 1.336 . . . . 0.0 112.347 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.662 ' O ' ' N ' ' A' ' 94' ' ' GLU . . . -71.68 27.13 0.61 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' CB ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER 32.01 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -1.077 . . . . 0.0 109.998 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' A' ' 92' ' ' GLY . 26.6 mt-10 -42.71 170.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.645 ' CD ' ' H ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -78.27 130.14 35.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -54.12 130.01 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.7 90.45 0.89 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.09 117.64 10.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 109.244 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.3 173.46 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.865 . . . . 0.0 108.819 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.541 ' O ' ' C ' ' A' ' 101' ' ' TRP . 0.3 OUTLIER -128.57 145.31 51.17 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.541 ' C ' ' O ' ' A' ' 100' ' ' THR . 13.8 t-105 -32.6 -65.72 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.625 -0.672 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.504 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 4.2 tp10 -41.81 -43.43 2.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.749 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 100' ' ' THR . 3.0 mt-30 -66.89 -57.08 7.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 110.238 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 105' ' ' LEU . 1.5 m -56.14 -41.69 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.136 . . . . 0.0 109.138 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 108' ' ' ALA . 33.2 mt -59.17 -68.03 0.31 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -0.954 . . . . 0.0 109.112 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 105' ' ' LEU . 73.2 tt0 -46.59 -31.97 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 108.938 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.425 HG12 ' CD1' ' A' ' 77' ' ' LEU . 29.4 mt -75.39 -26.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.707 ' O ' ' N ' ' A' ' 111' ' ' LYS . . . -88.13 -54.05 4.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.764 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 108' ' ' ALA . 2.2 mtpt -32.14 -59.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -21.01 66.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.096 -1.002 . . . . 0.0 109.715 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 108' ' ' ALA . 6.3 tmtt? -99.16 21.16 12.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.754 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 4.8 ppp? -157.46 39.86 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.032 . . . . 0.0 110.412 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 112' ' ' MET . 7.5 Cg_exo -46.05 -28.8 5.59 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 120.963 1.108 . . . . 0.0 111.926 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 113' ' ' PRO . 0.8 OUTLIER 158.98 10.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.458 ' N ' HD22 ' A' ' 115' ' ' LEU . 3.5 mm? -52.82 -104.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.777 . . . . 0.0 110.992 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.401 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -88.14 -32.04 18.86 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.717 ' CG2' ' H ' ' A' ' 118' ' ' THR . 5.9 m -78.27 -145.22 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.424 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.717 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER 167.67 -69.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 118' ' ' THR . 1.2 m-20 -80.08 166.32 21.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.286 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 121' ' ' GLU . 4.1 mt -75.5 -52.29 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.627 ' CD ' ' N ' ' A' ' 122' ' ' ALA . 2.9 pp20? -36.13 -45.97 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 109.578 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.627 ' N ' ' CD ' ' A' ' 121' ' ' GLU . . . -60.99 -71.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.0 -43.93 66.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.965 . . . . 0.0 109.004 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.46 ' HB1' ' CH2' ' A' ' 101' ' ' TRP . . . -44.19 -58.47 2.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.033 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -41.91 91.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.077 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.2 ttp -52.47 -38.5 59.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 128' ' ' ALA . 8.6 mm -83.63 -71.26 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.296 -0.877 . . . . 0.0 109.34 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 127' ' ' ILE . . . -40.05 -36.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 130' ' ' SER . . . -72.62 -60.52 3.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.542 ' C ' ' O ' ' A' ' 129' ' ' GLY . 35.3 m -37.47 -48.22 0.95 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.157 . . . . 0.0 108.434 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -64.89 -46.9 79.82 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' GLY . 3.2 tmt_? -43.84 -51.07 7.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.792 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.639 ' C ' ' H ' ' A' ' 135' ' ' GLY . 6.2 t -65.07 -41.73 94.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.677 ' C ' ' H ' ' A' ' 136' ' ' VAL . 16.3 ttp -66.14 30.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 66.76 -21.5 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.677 ' H ' ' C ' ' A' ' 134' ' ' MET . 72.0 t -61.51 163.21 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.417 -1.049 . . . . 0.0 109.289 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' H ' HG13 ' A' ' 136' ' ' VAL . 23.0 mm-40 -139.5 147.86 41.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 0.0 109.571 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.62 119.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.196 -0.94 . . . . 0.0 108.972 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 140' ' ' GLY . 1.2 p -87.44 -43.03 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 139' ' ' VAL . . . -76.12 -119.62 0.14 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 140' ' ' GLY . . . 36.05 65.21 2.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.271 -1.135 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 144' ' ' VAL . 5.2 Cg_exo -57.25 105.19 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.627 1.551 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 142' ' ' PRO . 1.2 mm-40 -38.45 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.401 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 142' ' ' PRO . 2.4 m -83.87 112.19 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.634 ' CG ' ' H ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -116.2 -112.39 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.476 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.634 ' H ' ' CG ' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -55.85 -4.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.34 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -113.52 139.99 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.428 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 4' ' ' VAL . 29.3 tttm -175.9 82.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 3' ' ' LYS . 1.2 p -38.38 145.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -108.44 -32.96 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' ILE . . . -153.3 141.84 20.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 7' ' ' VAL . 5.1 p -145.15 115.91 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.877 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' HD12 ' A' ' 57' ' ' ILE . 2.5 t -92.86 114.91 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.4 tmtt? -114.31 114.53 26.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.513 ' H ' HG23 ' A' ' 55' ' ' VAL . 2.4 tp -157.55 -176.52 6.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.124 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 3.1 pm0 -114.84 120.48 40.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.0 109.476 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -115.28 151.55 45.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.366 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.89 123.08 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.601 1.534 . . . . 0.0 112.361 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -75.78 129.02 36.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.928 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.611 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 67.45 47.71 61.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -176.85 -21.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.801 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.98 144.22 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.581 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.687 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -131.64 162.75 54.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.44 16.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.543 1.496 . . . . 0.0 113.012 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.03 58.52 15.74 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.427 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.1 Cg_endo -70.39 169.9 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.58 1.52 . . . . 0.0 112.449 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.9 -6.91 5.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.478 1.452 . . . . 0.0 111.673 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.91 HG13 ' HB3' ' A' ' 26' ' ' ALA . 91.4 t -114.87 -54.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.531 -0.731 . . . . 0.0 109.135 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 23' ' ' VAL . . . 36.21 -99.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' VAL . 11.6 Cg_exo -46.62 -43.41 22.93 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.325 1.35 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.91 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -70.68 -5.02 26.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.349 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD13 ' CD2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -97.13 -43.89 7.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.426 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.74 73.45 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.662 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.2 tm0? -123.86 6.55 8.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.332 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.678 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 7.1 p80 -116.16 -47.24 2.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -152.63 -2.69 0.18 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 79.37 57.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 109.521 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.678 ' OD1' ' CE1' ' A' ' 30' ' ' HIS . 4.3 m120 -133.36 102.46 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.17 -39.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 109.832 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.628 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -61.3 -66.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -0.963 . . . . 0.0 109.486 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.57 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -34.68 -45.83 0.26 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 108.788 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.672 ' CD2' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -58.93 -66.91 0.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.97 -36.62 76.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.213 -0.929 . . . . 0.0 109.909 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' O ' ' A' ' 35' ' ' MET . 4.7 tptm -48.97 -61.78 1.88 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.297 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 43' ' ' ALA . . . -57.56 -48.49 79.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 45' ' ' THR . 18.3 t80 -47.56 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.4 m120 -38.52 -43.57 0.87 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 40' ' ' ALA . . . -49.87 -56.78 9.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 108.806 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -63.96 -53.59 47.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.192 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -65.28 -12.99 57.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.435 -0.791 . . . . 0.0 109.475 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -90.86 -30.62 16.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.097 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -82.69 -33.05 27.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.315 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.668 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -86.49 -77.93 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.668 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 177.69 -160.57 27.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 11.4 t70 -96.06 153.0 18.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 168.72 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.956 . . . . 0.0 109.768 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -124.77 148.81 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.845 HG12 ' OG1' ' A' ' 69' ' ' THR . 1.1 t -144.33 120.89 6.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.767 -1.208 . . . . 0.0 110.908 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 4.9 Cg_endo -68.47 85.84 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.227 1.285 . . . . 0.0 111.551 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' LEU . 3.5 m -57.16 149.82 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.03 . . . . 0.0 110.374 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 6.4 tt0 -138.51 53.48 1.79 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.489 HD13 HD21 ' A' ' 27' ' ' LEU . 2.7 mt -57.91 97.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.27 0.557 . . . . 0.0 110.172 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.42 ' HA ' HG23 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -86.87 97.49 10.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.718 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' ALA . 91.5 mt -82.06 110.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' O ' ' C ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -88.85 149.75 23.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.518 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -32.83 -55.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.877 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' C ' ' A' ' 63' ' ' ARG . 14.9 m-20 -62.45 43.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.298 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.676 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 36.49 49.7 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.193 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -110.18 117.27 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -101.61 98.82 9.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.109 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -102.02 125.41 48.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.649 ' CD1' ' O ' ' A' ' 67' ' ' PHE . 55.2 p90 -172.0 119.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.94 112.45 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 108.456 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.845 ' OG1' HG12 ' A' ' 53' ' ' VAL . 8.1 t -155.98 138.01 14.54 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' CG ' ' C ' ' A' ' 69' ' ' THR . 6.2 mttt -151.02 -73.15 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 109.404 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -89.29 164.05 31.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 71' ' ' THR . 25.9 Cg_exo -32.46 162.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.062 1.841 . . . . 0.0 112.842 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' TYR . 37.1 Cg_exo -36.1 -109.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.472 2.115 . . . . 0.0 113.793 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.97 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -14.35 -48.94 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.657 -0.652 . . . . 0.0 111.469 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.05 -31.72 65.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.931 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 9.6 p90 -30.76 -40.36 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.584 -0.698 . . . . 0.0 110.392 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.109 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -137.4 -18.06 1.3 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.955 -1.091 . . . . 0.0 108.868 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.109 ' N ' HD23 ' A' ' 77' ' ' LEU . 32.5 mt -64.38 -31.41 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.531 ' NE ' ' OG1' ' A' ' 71' ' ' THR . 12.0 mtm180 -54.85 -72.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 108.96 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.82 -40.88 61.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 108.796 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.78 72.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.327 -0.858 . . . . 0.0 109.113 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.629 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -81.22 -74.98 0.3 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' GLU . . . 160.87 6.11 0.05 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.523 HD21 ' CA ' ' A' ' 97' ' ' GLY . 11.4 mt -63.71 74.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -1.115 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLY . 14.1 mt-10 -86.01 -101.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.546 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 87' ' ' GLY . 28.0 mttp -131.25 165.13 24.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.608 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 88' ' ' ALA . . . -42.29 -34.82 1.66 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 87' ' ' GLY . . . 65.1 134.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -1.183 . . . . 0.0 109.363 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -34.47 78.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.387 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.7 150.0 37.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 93' ' ' ARG . 2.8 Cg_endo -57.05 135.05 68.45 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.305 1.336 . . . . 0.0 112.347 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.662 ' O ' ' N ' ' A' ' 94' ' ' GLU . . . -71.68 27.13 0.61 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.804 HH11 ' CB ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 32.01 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -1.077 . . . . 0.0 109.998 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' A' ' 92' ' ' GLY . 26.6 mt-10 -42.71 170.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.71 ' CD ' ' H ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -78.27 130.14 35.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG22 HD22 ' A' ' 84' ' ' LEU . 12.2 p -54.12 130.01 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.523 ' CA ' HD21 ' A' ' 84' ' ' LEU . . . 85.7 90.45 0.89 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' NE ' HG23 ' A' ' 139' ' ' VAL . 1.8 mtt180 -141.09 117.64 10.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 109.244 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.575 HD12 HG12 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -117.3 173.46 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.865 . . . . 0.0 108.819 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.824 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.3 OUTLIER -128.57 145.31 51.17 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.793 ' NE1' HD11 ' A' ' 105' ' ' LEU . 13.8 t-105 -32.6 -65.72 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.625 -0.672 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.504 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 4.2 tp10 -41.81 -43.43 2.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.749 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 100' ' ' THR . 3.0 mt-30 -66.89 -57.08 7.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 110.238 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.575 HG12 HD12 ' A' ' 99' ' ' ILE . 1.5 m -56.14 -41.69 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.136 . . . . 0.0 109.138 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.793 HD11 ' NE1' ' A' ' 101' ' ' TRP . 33.2 mt -59.17 -68.03 0.31 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -0.954 . . . . 0.0 109.112 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 105' ' ' LEU . 73.2 tt0 -46.59 -31.97 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 108.938 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.822 HG12 HD11 ' A' ' 77' ' ' LEU . 29.4 mt -75.39 -26.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.813 ' HB1' ' HB1' ' A' ' 123' ' ' ALA . . . -88.13 -54.05 4.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.764 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.825 ' HG2' HD21 ' A' ' 120' ' ' LEU . 2.2 mtpt -32.14 -59.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -21.01 66.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.096 -1.002 . . . . 0.0 109.715 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 108' ' ' ALA . 6.3 tmtt? -99.16 21.16 12.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.754 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 4.8 ppp? -157.46 39.86 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.032 . . . . 0.0 110.412 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 112' ' ' MET . 7.5 Cg_exo -46.05 -28.8 5.59 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 120.963 1.108 . . . . 0.0 111.926 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 113' ' ' PRO . 0.8 OUTLIER 158.98 10.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ASP . 3.5 mm? -52.82 -104.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.777 . . . . 0.0 110.992 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -88.14 -32.04 18.86 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.965 HG22 ' H ' ' A' ' 118' ' ' THR . 5.9 m -78.27 -145.22 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.424 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.965 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 167.67 -69.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.715 ' H ' HG23 ' A' ' 118' ' ' THR . 1.2 m-20 -80.08 166.32 21.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.286 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.825 HD21 ' HG2' ' A' ' 109' ' ' LYS . 4.1 mt -75.5 -52.29 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.627 ' CD ' ' N ' ' A' ' 122' ' ' ALA . 2.9 pp20? -36.13 -45.97 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 109.578 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.627 ' N ' ' CD ' ' A' ' 121' ' ' GLU . . . -60.99 -71.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.813 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -53.0 -43.93 66.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.965 . . . . 0.0 109.004 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.518 ' HB1' ' CH2' ' A' ' 101' ' ' TRP . . . -44.19 -58.47 2.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.033 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -41.91 91.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.077 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.2 ttp -52.47 -38.5 59.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.687 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 8.6 mm -83.63 -71.26 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.296 -0.877 . . . . 0.0 109.34 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 127' ' ' ILE . . . -40.05 -36.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 130' ' ' SER . . . -72.62 -60.52 3.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.542 ' C ' ' O ' ' A' ' 129' ' ' GLY . 35.3 m -37.47 -48.22 0.95 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.157 . . . . 0.0 108.434 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -64.89 -46.9 79.82 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' GLY . 3.2 tmt_? -43.84 -51.07 7.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.792 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.604 ' C ' ' H ' ' A' ' 135' ' ' GLY . 6.2 t -65.07 -41.73 94.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.644 ' C ' ' H ' ' A' ' 136' ' ' VAL . 16.3 ttp -66.14 30.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 66.76 -21.5 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 72.0 t -61.51 163.21 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.417 -1.049 . . . . 0.0 109.289 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 136' ' ' VAL . 23.0 mm-40 -139.5 147.86 41.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 0.0 109.571 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -74.62 119.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.196 -0.94 . . . . 0.0 108.972 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.824 ' CG1' HG22 ' A' ' 100' ' ' THR . 1.2 p -87.44 -43.03 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 139' ' ' VAL . . . -76.12 -119.62 0.14 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 140' ' ' GLY . . . 36.05 65.21 2.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.271 -1.135 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 144' ' ' VAL . 5.2 Cg_exo -57.25 105.19 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.627 1.551 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 142' ' ' PRO . 1.2 mm-40 -38.45 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.401 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 142' ' ' PRO . 2.4 m -83.87 112.19 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.607 ' CG ' ' H ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -116.2 -112.39 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.476 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.607 ' H ' ' CG ' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -55.85 -4.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.34 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtp . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -113.52 139.99 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.428 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.503 ' O ' ' C ' ' A' ' 4' ' ' VAL . 29.3 tttm -175.9 82.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 3' ' ' LYS . 1.2 p -38.38 145.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -0.97 . . . . 0.0 109.407 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -108.44 -32.96 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' ILE . . . -153.3 141.84 20.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 7' ' ' VAL . 5.1 p -145.15 115.91 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.877 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' HD12 ' A' ' 57' ' ' ILE . 2.5 t -92.86 114.91 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.122 -0.986 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.4 tmtt? -114.31 114.53 26.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.513 ' H ' HG23 ' A' ' 55' ' ' VAL . 2.4 tp -157.55 -176.52 6.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.124 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -114.84 120.48 40.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.0 109.476 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -115.28 151.55 45.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.366 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -68.89 123.08 10.01 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.601 1.534 . . . . 0.0 112.361 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -75.78 129.02 36.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.928 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.611 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 67.45 47.71 61.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -176.85 -21.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -1.182 . . . . 0.0 109.801 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.98 144.22 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.581 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.687 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -131.64 162.75 54.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.453 -0.78 . . . . 0.0 108.927 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -51.44 16.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.543 1.496 . . . . 0.0 113.012 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.03 58.52 15.74 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.083 -1.011 . . . . 0.0 109.427 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.1 Cg_endo -70.39 169.9 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.58 1.52 . . . . 0.0 112.449 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.9 -6.91 5.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.478 1.452 . . . . 0.0 111.673 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.91 HG13 ' HB3' ' A' ' 26' ' ' ALA . 91.4 t -114.87 -54.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.531 -0.731 . . . . 0.0 109.135 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 23' ' ' VAL . . . 36.21 -99.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' VAL . 11.6 Cg_exo -46.62 -43.41 22.93 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.325 1.35 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.91 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -70.68 -5.02 26.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.349 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD13 ' CD2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -97.13 -43.89 7.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.426 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.74 73.45 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.662 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.2 tm0? -123.86 6.55 8.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -1.151 . . . . 0.0 109.332 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.678 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 7.1 p80 -116.16 -47.24 2.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.917 . . . . 0.0 109.54 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -152.63 -2.69 0.18 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 79.37 57.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.153 . . . . 0.0 109.521 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.678 ' OD1' ' CE1' ' A' ' 30' ' ' HIS . 4.3 m120 -133.36 102.46 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.17 -39.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.91 . . . . 0.0 109.832 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.628 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -61.3 -66.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -0.963 . . . . 0.0 109.486 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.57 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -34.68 -45.83 0.26 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 108.788 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.672 ' CD2' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -58.93 -66.91 0.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG12 ' ND2' ' A' ' 42' ' ' ASN . 39.5 t -67.97 -36.62 76.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.213 -0.929 . . . . 0.0 109.909 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' O ' ' A' ' 35' ' ' MET . 4.7 tptm -48.97 -61.78 1.88 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.297 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 43' ' ' ALA . . . -57.56 -48.49 79.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.624 ' O ' HG23 ' A' ' 45' ' ' THR . 18.3 t80 -47.56 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.1 m-80 -38.52 -43.57 0.87 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 40' ' ' ALA . . . -49.87 -56.78 9.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 108.806 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -63.96 -53.59 47.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.192 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -65.28 -12.99 57.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.435 -0.791 . . . . 0.0 109.475 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -90.86 -30.62 16.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.097 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -82.69 -33.05 27.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.315 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.668 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -86.49 -77.93 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.668 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 177.69 -160.57 27.22 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 11.4 t70 -96.06 153.0 18.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 168.72 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -0.956 . . . . 0.0 109.768 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -124.77 148.81 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.845 HG12 ' OG1' ' A' ' 69' ' ' THR . 1.1 t -144.33 120.89 6.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.767 -1.208 . . . . 0.0 110.908 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 4.9 Cg_endo -68.47 85.84 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.227 1.285 . . . . 0.0 111.551 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 10' ' ' LEU . 3.5 m -57.16 149.82 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.03 . . . . 0.0 110.374 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 6.4 tt0 -138.51 53.48 1.79 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.489 HD13 HD21 ' A' ' 27' ' ' LEU . 2.7 mt -57.91 97.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.27 0.557 . . . . 0.0 110.172 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.42 ' HA ' HG23 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -86.87 97.49 10.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.718 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' ALA . 91.5 mt -82.06 110.44 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' O ' ' C ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -88.85 149.75 23.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.518 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -32.83 -55.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.877 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' O ' ' C ' ' A' ' 63' ' ' ARG . 14.9 m-20 -62.45 43.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.298 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.676 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 36.49 49.7 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.255 -0.903 . . . . 0.0 109.193 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -110.18 117.27 33.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.569 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -101.61 98.82 9.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.109 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 p -102.02 125.41 48.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.649 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 55.2 p90 -172.0 119.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.94 112.45 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 0.0 108.456 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.845 ' OG1' HG12 ' A' ' 53' ' ' VAL . 8.1 t -155.98 138.01 14.54 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' CG ' ' C ' ' A' ' 69' ' ' THR . 6.2 mttt -151.02 -73.15 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 109.404 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -89.29 164.05 31.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 71' ' ' THR . 25.9 Cg_exo -32.46 162.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.062 1.841 . . . . 0.0 112.842 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' TYR . 37.1 Cg_exo -36.1 -109.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.472 2.115 . . . . 0.0 113.793 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.97 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -14.35 -48.94 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.657 -0.652 . . . . 0.0 111.469 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -57.05 -31.72 65.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 110.542 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.931 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 9.6 p90 -30.76 -40.36 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.584 -0.698 . . . . 0.0 110.392 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.109 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -137.4 -18.06 1.3 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.955 -1.091 . . . . 0.0 108.868 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.109 ' N ' HD23 ' A' ' 77' ' ' LEU . 32.5 mt -64.38 -31.41 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.531 ' NE ' ' OG1' ' A' ' 71' ' ' THR . 12.0 mtm180 -54.85 -72.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 108.96 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.82 -40.88 61.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 108.796 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.78 72.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.327 -0.858 . . . . 0.0 109.113 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.629 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -81.22 -74.98 0.3 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' GLU . . . 160.87 6.11 0.05 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.523 HD21 ' CA ' ' A' ' 97' ' ' GLY . 11.4 mt -63.71 74.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -1.115 . . . . 0.0 109.32 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLY . 14.1 mt-10 -86.01 -101.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.546 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 87' ' ' GLY . 28.0 mttp -131.25 165.13 24.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 109.608 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 88' ' ' ALA . . . -42.29 -34.82 1.66 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 87' ' ' GLY . . . 65.1 134.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -1.183 . . . . 0.0 109.363 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.2 -34.47 78.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.387 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.7 150.0 37.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.098 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 93' ' ' ARG . 2.8 Cg_endo -57.05 135.05 68.45 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.305 1.336 . . . . 0.0 112.347 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.662 ' O ' ' N ' ' A' ' 94' ' ' GLU . . . -71.68 27.13 0.61 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.804 ' CB ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER 32.01 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -1.077 . . . . 0.0 109.998 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' A' ' 92' ' ' GLY . 26.6 mt-10 -42.71 170.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.71 ' CD ' ' H ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -78.27 130.14 35.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG22 HD22 ' A' ' 84' ' ' LEU . 12.2 p -54.12 130.01 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.523 ' CA ' HD21 ' A' ' 84' ' ' LEU . . . 85.7 90.45 0.89 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' NE ' HG23 ' A' ' 139' ' ' VAL . 1.8 mtt180 -141.09 117.64 10.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 109.244 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.575 HD12 HG12 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -117.3 173.46 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.865 . . . . 0.0 108.819 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.824 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.3 OUTLIER -128.57 145.31 51.17 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.793 ' NE1' HD11 ' A' ' 105' ' ' LEU . 13.8 t-105 -32.6 -65.72 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.625 -0.672 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.504 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 4.2 tp10 -41.81 -43.43 2.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.749 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 100' ' ' THR . 3.0 mt-30 -66.89 -57.08 7.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.25 -0.906 . . . . 0.0 110.238 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.575 HG12 HD12 ' A' ' 99' ' ' ILE . 1.5 m -56.14 -41.69 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.882 -1.136 . . . . 0.0 109.138 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.793 HD11 ' NE1' ' A' ' 101' ' ' TRP . 33.2 mt -59.17 -68.03 0.31 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -0.954 . . . . 0.0 109.112 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 105' ' ' LEU . 73.2 tt0 -46.59 -31.97 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 108.938 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.822 HG12 HD11 ' A' ' 77' ' ' LEU . 29.4 mt -75.39 -26.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.813 ' HB1' ' HB1' ' A' ' 123' ' ' ALA . . . -88.13 -54.05 4.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 109.764 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.825 ' HG2' HD21 ' A' ' 120' ' ' LEU . 2.2 mtpt -32.14 -59.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -21.01 66.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.096 -1.002 . . . . 0.0 109.715 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 108' ' ' ALA . 6.3 tmtt? -99.16 21.16 12.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 109.754 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 4.8 ppp? -157.46 39.86 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.05 -1.032 . . . . 0.0 110.412 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 112' ' ' MET . 7.5 Cg_exo -46.05 -28.8 5.59 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 120.963 1.108 . . . . 0.0 111.926 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 113' ' ' PRO . 0.8 OUTLIER 158.98 10.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ASP . 3.5 mm? -52.82 -104.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.456 -0.777 . . . . 0.0 110.992 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.401 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -88.14 -32.04 18.86 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.965 HG22 ' H ' ' A' ' 118' ' ' THR . 5.9 m -78.27 -145.22 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.424 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.965 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 167.67 -69.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.715 ' H ' HG23 ' A' ' 118' ' ' THR . 1.2 m-20 -80.08 166.32 21.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.286 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.825 HD21 ' HG2' ' A' ' 109' ' ' LYS . 4.1 mt -75.5 -52.29 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.627 ' CD ' ' N ' ' A' ' 122' ' ' ALA . 2.9 pp20? -36.13 -45.97 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 109.578 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.627 ' N ' ' CD ' ' A' ' 121' ' ' GLU . . . -60.99 -71.98 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.813 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -53.0 -43.93 66.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.965 . . . . 0.0 109.004 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.518 ' HB1' ' CH2' ' A' ' 101' ' ' TRP . . . -44.19 -58.47 2.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.033 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -41.91 91.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.077 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.2 ttp -52.47 -38.5 59.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.013 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.687 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 8.6 mm -83.63 -71.26 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.296 -0.877 . . . . 0.0 109.34 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 127' ' ' ILE . . . -40.05 -36.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 130' ' ' SER . . . -72.62 -60.52 3.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.542 ' C ' ' O ' ' A' ' 129' ' ' GLY . 35.3 m -37.47 -48.22 0.95 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -1.157 . . . . 0.0 108.434 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -64.89 -46.9 79.82 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 129' ' ' GLY . 3.2 tmt_? -43.84 -51.07 7.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.792 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.604 ' C ' ' H ' ' A' ' 135' ' ' GLY . 6.2 t -65.07 -41.73 94.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.644 ' C ' ' H ' ' A' ' 136' ' ' VAL . 16.3 ttp -66.14 30.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 66.76 -21.5 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 72.0 t -61.51 163.21 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.417 -1.049 . . . . 0.0 109.289 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 136' ' ' VAL . 23.0 mm-40 -139.5 147.86 41.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 0.0 109.571 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -74.62 119.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.196 -0.94 . . . . 0.0 108.972 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.824 ' CG1' HG22 ' A' ' 100' ' ' THR . 1.2 p -87.44 -43.03 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 139' ' ' VAL . . . -76.12 -119.62 0.14 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 140' ' ' GLY . . . 36.05 65.21 2.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.271 -1.135 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 144' ' ' VAL . 5.2 Cg_exo -57.25 105.19 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.627 1.551 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 142' ' ' PRO . 1.2 mm-40 -38.45 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.401 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 142' ' ' PRO . 2.4 m -83.87 112.19 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.607 ' CG ' ' H ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -116.2 -112.39 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.476 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.607 ' H ' ' CG ' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -55.85 -4.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.34 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.478 179.973 . . . . . . . . 1 1 . 1 stop_ save_